Renaissance Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$31.6M	Buy	251,732 +39,632	+19%	+$4.98M	1.23%	44
2025 Q1	$23.5M	Sell	212,100 -5,472	-3%	-$605K	1.03%	53
2024 Q4	$29.7M	Buy	217,572 +13,432	+7%	+$1.83M	1.23%	44
2024 Q3	$23.5M	Buy	+204,140	New	+$23.5M	0.97%	54